Nonthavej Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,373	2,484	2,472	2,255	1,786	1,876
Other Revenue	12.05	15.57	13.19	14.83	16.13	15.7
Revenue	2,385	2,500	2,485	2,270	1,802	1,892
Revenue Growth (YoY)	-5.99%	0.61%	9.45%	25.98%	-4.76%	-17.19%
Cost of Revenue	1,729	1,744	1,707	1,599	1,345	1,352
Gross Profit	656.27	755.76	777.82	671.24	457.29	540.08
Selling, General & Admin	331.89	328.42	311.51	290.96	262.07	265.27
Operating Expenses	329.34	325.21	306.18	300.65	266.56	269.68
Operating Income	326.94	430.55	471.64	370.59	190.73	270.39
Interest & Investment Income	22.52	19.02	11.69	4.54	3.56	6.28
EBT Excluding Unusual Items	349.46	449.57	483.33	375.13	194.3	276.67
Gain (Loss) on Sale of Investments	-0.11	-0.17	-0.08	-0.19	0.19	-0.02
Pretax Income	349.35	449.4	483.25	374.94	194.49	276.66
Income Tax Expense	68.85	88.66	95.5	74.37	35.12	45.84
Net Income	280.5	360.74	387.75	300.56	159.37	230.82
Net Income to Common	280.5	360.74	387.75	300.56	159.37	230.82
Net Income Growth	-27.70%	-6.96%	29.01%	88.59%	-30.95%	-45.12%
Shares Outstanding (Basic)	160	160	160	160	160	160
Shares Outstanding (Diluted)	160	160	160	160	160	160
EPS (Basic)	1.75	2.25	2.42	1.88	1.00	1.44
EPS (Diluted)	1.75	2.25	2.42	1.88	1.00	1.44
EPS Growth	-27.70%	-6.96%	29.01%	88.59%	-30.95%	-45.12%
Free Cash Flow	227.61	356.72	408.45	379.07	111.13	1,153
Free Cash Flow Per Share	1.42	2.23	2.55	2.37	0.69	7.21
Dividend Per Share	1.370	1.370	1.460	1.130	0.600	0.870
Dividend Growth	-6.16%	-6.16%	29.20%	88.33%	-31.03%	-44.94%
Gross Margin	27.52%	30.23%	31.30%	29.57%	25.38%	28.54%
Operating Margin	13.71%	17.22%	18.98%	16.32%	10.58%	14.29%
Profit Margin	11.76%	14.43%	15.60%	13.24%	8.84%	12.20%
Free Cash Flow Margin	9.54%	14.27%	16.44%	16.70%	6.17%	60.94%
EBITDA	512.91	607.88	638.39	545.47	348.04	405.89
EBITDA Margin	21.51%	24.32%	25.69%	24.03%	19.31%	21.45%
D&A For EBITDA	185.97	177.33	166.75	174.88	157.3	135.5
EBIT	326.94	430.55	471.64	370.59	190.73	270.39
EBIT Margin	13.71%	17.22%	18.98%	16.32%	10.58%	14.29%
Effective Tax Rate	19.71%	19.73%	19.76%	19.84%	18.06%	16.57%
Revenue as Reported	2,385	2,500	2,485	2,270	1,802	1,892

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.